Compounds > suplatast tosilate
Page last updated: 2024-08-25

suplatast tosilate and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

suplatast tosilate has been researched along with (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sano, Y1
Aoshiba, K; Isono, K; Kondo, M; Nagai, A; Nakata, J; Sakai, N; Tagaya, E; Tamaoki, J1
Bando, H; Nakamura, Y; Nii, A; Sano, T; Sone, S; Yanagawa, H; Yoshida, S1
Arakawa, M; Fujimori, K; Gejyo, F; Shimatsu, Y; Suzuki, E1

Trials

2 trial(s) available for suplatast tosilate and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

ArticleYear
Effect of suplatast tosilate, a Th2 cytokine inhibitor, on steroid-dependent asthma: a double-blind randomised study. Tokyo Joshi-Idai Asthma Research Group.
    Lancet (London, England), 2000, Jul-22, Volume: 356, Issue:9226

    Topics: Administration, Inhalation; Administration, Oral; Anti-Allergic Agents; Anti-Asthmatic Agents; Arylsulfonates; Asthma; Beclomethasone; Circadian Rhythm; Cytokines; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Peak Expiratory Flow Rate; Sulfonium Compounds; Th2 Cells

2000
Add-on effects of suplatast tosilate in bronchial asthma patients treated with inhaled corticosteroids.
    Lung, 2003, Volume: 181, Issue:4

    Topics: Administration, Inhalation; Adult; Anti-Asthmatic Agents; Arylsulfonates; Asthma; Beclomethasone; Cytokines; Histamine Antagonists; Humans; Peak Expiratory Flow Rate; Sulfonium Compounds; Th2 Cells

2003

Other Studies

2 other study(ies) available for suplatast tosilate and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

ArticleYear
[Anti-inflammatory drugs for the treatment of bronchial hyperresponsiveness].
    Nihon Kyobu Shikkan Gakkai zasshi, 1996, Volume: 34 Suppl

    Topics: Administration, Inhalation; Administration, Oral; Adult; Aged; Anti-Allergic Agents; Anti-Inflammatory Agents; Arylsulfonates; Asthma; Beclomethasone; Bronchial Hyperreactivity; Female; Humans; Male; Middle Aged; Sulfonium Compounds

1996
[Chronic eosinophilic pneumonia complicated by bronchial asthma and diabetes mellitus successfully treated with suplatast tosilate and high-dose inhaled corticosteroid therapy].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 1999, Volume: 37, Issue:11

    Topics: Administration, Inhalation; Anti-Asthmatic Agents; Arylsulfonates; Asthma; Beclomethasone; Chronic Disease; Diabetes Complications; Diabetes Mellitus; Female; Humans; Interleukin-5; Middle Aged; Pulmonary Eosinophilia; Sulfonium Compounds

1999